HUMA: Humacyte Inc

2.37 USD 0.10 (4.05%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

HUMA exchange rate has changed by -4.05% for today. During the day, the instrument was traded at a low of 2.36 and at a high of 2.52.

Follow Humacyte Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

HUMA News

Zacks 22:00 Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts
Zacks 22:15 Humacyte, Inc. (HUMA) Stock Falls Amid Market Uptick: What Investors Need to Know
Benzinga 15:00 GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday - Arrowhead Pharma (NASDAQ:ARWR), Abivax (NASDAQ:ABVX)
Investing 13:12 Humacyte stock rises after first Symvess sale to US Military facility
Zacks 22:00 Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know
Zacks 22:15 Why Humacyte, Inc. (HUMA) Dipped More Than Broader Market Today
Benzinga 17:25 Gold Falls 1%; ProKidney Shares Spike Higher - Apogee Therapeutics (NASDAQ:APGE), Blue Gold (NASDAQ:BGL)
Investing 15:26 Humacyte stock soars after Symvess gains DOD electronic catalog listing
Investing 12:17 Humacyte’s Symvess gains DOD electronic catalog listing approval
Investing 13:20 BTCC Exchange Reports Remarkable Q2 2025 Performance with $957 Billion Trading Volume
Seeking Alpha 13:05 Humacyte: Revenue Ramp From Symvess Incoming (NASDAQ:HUMA)
Investing 12:32 Results from Humacyte’s V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting
Seeking Alpha 05:57 Humacyte Paradoxically Scales Back As Symvess Begins Its Long Journey (NASDAQ:HUMA)
Investing 14:09 Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3
Investing 18:04 Humacyte at H.C. Wainwright Conference: Promising Developments in SimVess
Investing 20:32 Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq
Investing 14:37 Benchmark cuts Humacyte stock target to $14, maintains Buy rating
Benzinga 20:56 Small-Caps Explode Higher As Tariff Fears Ease: Humacyte, Forward Air, FormFactor Top Russell 2000 - FormFactor (NASDAQ:FORM), FTAI Aviation (NASDAQ:FTAI)
Seeking Alpha 17:48 Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript
Investing 15:07 Humacyte shares tumble 10% as Q4 loss narrows but revenue remains elusive
Investing 21:59 Humacyte CEO addresses concerns in NYT over FDA approval of Symvess
Seeking Alpha 20:28 Humacyte: Doubts Cast Around Efficacy Of Symvess May Be Hard To Dispel (NASDAQ:HUMA)
Benzinga 14:47 Why Humacyte (HUMA) Stock Is Falling Sharply - Humacyte (NASDAQ:HUMA)
Investing 11:57 Humacyte stock plunges on public offering pricing

Daily Range

2.36 2.52

Year Range

1.15 9.68

Previous Close: 2.47
Open: 2.47

Bid: 2.37
Ask: 2.67

Low: 2.36
High: 2.52

Volume: 2.683 K

Daily Change: -4.05%
Month Change: 12.32%

6 Months Change: -46.14%
Year Change: -75.21%

30 July, Wednesday